COSCIENS Biopharma Announces Results From Phase 3 DETECT-Trial Of AEZS-130-P02; Primary Endpoint Was Not Met
COSCIENS Biopharma Announces Results From Phase 3 DETECT-Trial Of AEZS-130-P02; Primary Endpoint Was Not Met
COSCIENS生物製藥公司宣佈AEZS-130-P02的3期DETECt試驗結果，但未達到主要終點。
COSCIENS Biopharma Announces Results From Phase 3 DETECT-Trial Of AEZS-130-P02; Primary Endpoint Was Not Met
COSCIENS生物製藥公司宣佈AEZS-130-P02的3期DETECt試驗結果，但未達到主要終點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。